Bosutinib

Bosutinib

File:Bosutinib.png
Identifiers
IUPAC name 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile
CAS Number	380843-75-4
PubChem CID	5328940
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C26H29Cl2N5O3
Molar mass	530.446 g/mol

WikiDoc Resources for Bosutinib
Articles
Most recent articles on Bosutinib Most cited articles on Bosutinib Review articles on Bosutinib Articles on Bosutinib in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Bosutinib Images of Bosutinib Photos of Bosutinib Podcasts & MP3s on Bosutinib Videos on Bosutinib
Evidence Based Medicine
Cochrane Collaboration on Bosutinib Bandolier on Bosutinib TRIP on Bosutinib
Clinical Trials
Ongoing Trials on Bosutinib at Clinical Trials.gov Trial results on Bosutinib Clinical Trials on Bosutinib at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Bosutinib NICE Guidance on Bosutinib NHS PRODIGY Guidance FDA on Bosutinib CDC on Bosutinib
Books
Books on Bosutinib
News
Bosutinib in the news Be alerted to news on Bosutinib News trends on Bosutinib
Commentary
Blogs on Bosutinib
Definitions
Definitions of Bosutinib
Patient Resources / Community
Patient resources on Bosutinib Discussion groups on Bosutinib Patient Handouts on Bosutinib Directions to Hospitals Treating Bosutinib Risk calculators and risk factors for Bosutinib
Healthcare Provider Resources
Symptoms of Bosutinib Causes & Risk Factors for Bosutinib Diagnostic studies for Bosutinib Treatment of Bosutinib
Continuing Medical Education (CME)
CME Programs on Bosutinib
International
Bosutinib en Espanol Bosutinib en Francais
Business
Bosutinib in the Marketplace Patents on Bosutinib
Experimental / Informatics
List of terms related to Bosutinib

Overview

Bosutinib (rINN/USAN; codenamed SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.

It is being developed by Wyeth.